Photo from wikipedia
Treatment of Helicobacter pylori infection is often empiric; however, current guidelines for management of Helicobacter pylori infection advise against the use of standard triple therapy (clarithromycin, amoxicillin, and proton‐pump inhibitor)… Click to show full abstract
Treatment of Helicobacter pylori infection is often empiric; however, current guidelines for management of Helicobacter pylori infection advise against the use of standard triple therapy (clarithromycin, amoxicillin, and proton‐pump inhibitor) when clarithromycin resistance exceeds 20%. We developed and tested a new culture‐free assay to detect clarithromycin resistance‐conferring mutations to determine the prevalence of H. pylori clarithromycin resistance in patients from the United States Pacific Northwest.
Journal Title: Helicobacter
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!